Comparative Efficacy of Cardiovascular Risk Prediction Tools: A Network Meta-analysis of Traditional, Radiological, and AI-Based Approaches
摘要
Accurate cardiovascular disease (CVD) risk prediction is critical for preventive decision-making. While traditional tools like the Framingham Risk Score (FRS) and Coronary Artery Calcium Score (CACS) are widely used, newer artificial intelligence (AI)-based models such as AICVD and Reti-CVD offer promising alternatives. However, comparative data across traditional, radiological, and AI-based tools remain limited.
ObjectiveThis study aimed to compare the predictive efficacy of traditional, radiological, and AI-driven CVD risk tools through a network meta-analysis.
MethodsA systematic search of PubMed, Embase, Cochrane Library, and Google Scholar identified four observational studies comparing predictive tools in adults for ischemic CVD outcomes. Tools assessed included FRS, QRISK3, CACS, CIMT, baPWV, AICVD, and Reti-CVD. Primary outcomes were risk stratification accuracy and the incidence of ischemic CVD events during follow-up (up to 11 years). A network meta-analysis using random effects models was performed in R.
ResultsA total of four observational studies with 53,641 participants were included. AICVD demonstrated the highest predictive efficacy, with an 86% higher relative risk of identifying ischemic CVD compared to QRISK3 (RR: 1.86; 95% CI: 1.09–3.18). The combined use of CACS and FRS improved predictive accuracy (RR: 1.50), while CACS alone showed a modest benefit (RR: 1.29). Reti-CVD demonstrated comparable performance to CACS (RR: 0.87; 95% CI: 0.46–1.65), offering a non-invasive alternative without radiation exposure. Ranking analysis indicated AICVD > CACS + FRS > CACS > Reti-CVD > baPWV > CIMT > FRS > QRISK3.
ConclusionAI-based tools such as AICVD and Reti-CVD may outperform traditional methods in predicting ischemic CVD. Despite limited data, these findings highlight the potential of AI in risk prediction, warranting further validation across diverse populations.